A Case of Cutaneous Sarcoidosis Associated with Pegylated Interferon Alpha-2a and Ribavirin Therapy.
- Author:
Ki Hyun KWON
1
;
Dong Cheon HA
;
Jeong Hwa LEE
;
Tae Youn HEO
;
Young Yong AHN
;
Yeon Soo KIM
;
Dong Soo LEE
Author Information
1. Department of Internal Medicine, Daejeon St. Mary's Hospital, The Catholic University of Korea School of Medicine, Daejeon, Korea. grandbleu@catholic.ac.kr
- Publication Type:Case Report
- Keywords:
Hepatitis C;
Pegylated interferon alpha-2a;
Sarcoidosis
- MeSH:
Alopecia;
Bone Marrow;
Depression;
Hepatitis C;
Hepatitis C, Chronic;
Interferons;
Ribavirin;
Sarcoidosis;
Sleep Initiation and Maintenance Disorders
- From:Korean Journal of Medicine
2011;80(Suppl 2):S117-S120
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Pegylated interferon plus ribavirin is the standard treatment regimen in chronic hepatitis C. The main adverse events of pegylated interferon plus ribavirin combination therapy are bone marrow depression, alopecia, insomnia, and influenza-like symptoms. However, there are few reports of cutaneous sarcoidosis occurring during pegylated interferon alpha-2a and ribavirin therapy. Here, we report a case of cutaneous sarcoidosis induced by pegylated interferon alpha-2a and ribavirin during the treatment for chronic hepatitis C. The patient's sarcoidosis improved spontaneously after the treatment.
